Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 90: 1088-1094, 2001;
8750-7587/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azzam, Z. S.
Right arrow Articles by Sznajder, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azzam, Z. S.
Right arrow Articles by Sznajder, J. I.
Vol. 90, Issue 3, 1088-1094, March 2001

Catecholamines increase lung edema clearance in rats with increased left atrial pressure

Zaher S. Azzam1,2, Fernando J. Saldias3, Alejandro Comellas1, Karen M. Ridge1, David H. Rutschman4, and Jacob I. Sznajder1

1 Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago 60611; 4 Department of Mathematics, Northeastern Illinois University, Chicago, Illinois 60625; 2 Department of Medicine, Technion, Israel Institute of Technology, 31096 Haifa, Israel; and 3 Departamento de Enfermedades Respiratorias, Facultad de Medicina, Universidad Católica de Chile, Santiago, Chile


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS AND MATERIALS
RESULTS
DISCUSSION
REFERENCES

During hydrostatic pulmonary edema, active Na+ transport and alveolar fluid reabsorption are decreased. Dopamine (DA) and isoproterenol (ISO) have been shown to increase active Na+ transport in rat lungs by upregulating Na+-K+-ATPase in the alveolar epithelium. We studied the effects of DA and ISO in isolated rat lungs with increased left atrial pressure (Pla = 15 cmH2O) compared with control rats with normal Pla (Pla = 0). Alveolar fluid reabsorption decreased from control value of 0.51 ± 0.02 to 0.27 ± 0.02 ml/h when Pla was increased to 15 cmH2O (P < 0.001). DA and ISO increased the alveolar fluid reabsorption back to control levels. Treatment with the D1 antagonist SCH-23390 inhibited the stimulatory effects of DA (0.30 ± 0.02 ml/h), whereas fenoldopam, a specific D1-receptor agonist, increased alveolar fluid reabsorption in rats exposed to Pla of 15 cmH2O (0.47 ± 0.04 ml/h). Propranolol, a beta -adrenergic-receptor antagonist, blocked the stimulatory effects of ISO; however, it did not affect alveolar fluid reabsorption in control or DA-treated rats. Amiloride (a Na+ channel blocker) and ouabain (a Na+-K+-ATPase inhibitor), either alone or together, inhibited the stimulatory effects of DA. Colchicine, which disrupts the cellular microtubular transport of ion-transporting proteins to the plasma membrane, inhibited the stimulatory effects of DA, whereas the isomer beta -lumicolchicine did not block the stimulatory effects of DA. These data suggest that DA and ISO increase alveolar fluid reabsorption in a model of increased Pla by regulating active Na+ transport in rat alveolar epithelium. The effects of DA and ISO are mediated by the activation of dopaminergic D1 receptors and the beta -adrenergic receptors, respectively.

active sodium transport; cytoskeleton


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS AND MATERIALS
RESULTS
DISCUSSION
REFERENCES

PULMONARY EDEMA DEVELOPS as a result of either changes in the hydrostatic and/or oncotic pressure gradients across the pulmonary circulation or increased alveolocapillary permeability. As such, increased pulmonary capillary wedge pressures can result in pulmonary edema formation (13, 32). Several therapeutic options are available in clinical practice to reduce edema formation; however, approaches to increase alveolar fluid reabsorption (once edema has been formed) are less understood. Previous reports have suggested that vectorial Na+ transport and thus alveolar fluid reabsorption across the alveolocapillary barrier are important in keeping the air spaces free of edema (16, 23, 29). Alveolar fluid reabsorption is regulated in epithelial cells by the rate of sodium entry, via the apical Na+ channels, coupled to the rate of Na+ extrusion, via the basolateral Na+-K+-ATPase.

Dopamine (DA) induces natriuresis in the kidney by inhibiting the Na+-K+-ATPase. However, in the lungs, DA and isoproterenol (ISO) have been shown to increase active Na+ transport and thus alveolar fluid reabsorption in normal rats as well as in rats exposed to hyperoxia by regulating Na+-K+-ATPase function in the alveolar epithelium (3, 4, 27).

Recently, it has been shown that alveolar fluid reabsorption is impaired in the presence of elevated left atrial pressures (Pla) (Refs. 7 and 22, and Saldias FJ, Azzam ZS, Ridge KM, Yeldandi A, Rutschman DH, Schraufnagel D, Sznajder JI, unpublished observations). The purpose of this study was to determine whether DA and ISO would increase alveolar fluid reabsorption in a model of increased Pla and investigate mechanisms contributing to these effects.


    METHODS AND MATERIALS
TOP
ABSTRACT
INTRODUCTION
METHODS AND MATERIALS
RESULTS
DISCUSSION
REFERENCES

Isolated-perfused lung. The lungs and heart of rats anesthetized with 50 mg/kg body wt of intraperitoneal pentobarbital were removed en bloc after a 10-min ventilation with 100% O2 and anticoagulation with heparin as previously described (23, 28). The pulmonary artery and left atrium were catheterized and perfused continuously with a solution of 3% bovine serum albumin (BSA) in buffered physiological salt solution (135.5 mM Na+, 119.1 mM Cl-, 25 mM HCO3-, 4.1 mM K+, 2.8 mM Mg+, 2.5 mM Ca2+, 0.8 mM SO4-2, 8.3 mM glucose). Trace amounts of fluorescein-labeled (FITC) albumin were also added to the perfusate. The recirculating volume of the constant-pressure perfusion system was 90 ml; arterial and venous pressures were set at 15 and 0 cmH2O, respectively, in the group of rats with normal Pla and 20 and 15 cmH2O, respectively, in the increased Pla study groups. The vascular pressures were recorded every 10 s with a multichannel recorder (Cyber Sense, Nicholasville, KY). The lungs were immersed in a "pleural" bath (100 ml) filled with the same BSA solution. The entire system was maintained at 37°C in a water bath. Perfusate pH was maintained at 7.40 by bubbling with a gas mixture of 95% O2-5% CO2. The lungs were then instilled via tracheal cannula in two sequential phases with a total of 5-ml volume of the BSA solution containing 0.1 mg/ml Evans blue dye-labeled (EBD; Sigma Chemical, St. Louis, MO) albumin, 0.02 µCi/ml of 22Na+ (Du Pont-NEN, Boston, MA) and 0.12 µCi/ml of [3H]mannitol (Du Pont-NEN). Samples were taken from the instillate, perfusate, and bath solutions after an equilibration time of 10 min from the instillation and 60 min later. To ensure a homogeneous sampling of the instillate, a volume of 2 ml was aspirated and reintroduced into the air spaces three times before each sample was removed. All samples were centrifuged at 3,000 g for 10 min. Absorbance analysis of the supernatant or EBD albumin was performed at 620 nm in a Hitachi model U2000 spectrometer (Hitachi, San Jose, CA). Analysis of FITC-albumin (excitation 487 nm and emission 520 nm) was performed in a Perkin-Elmer fluorometer (model LS-3B, Perkin-Elmer, Oakbrook, IL). Scintillation counts (for 22Na+ and [3H]mannitol) were measured in a Beckman beta counter (model LS 6500, Beckman Instruments, Fullerton, CA).

Calculations. The mathematical calculation of lung liquid clearance, the movement of sodium, and the flux of mannitol were described elsewhere (23). Briefly, the amount of instilled EBD-albumin remains constant during the experimental protocol; thus any change in its concentration at a given time (t) will reflect the change in the air space volume (Vt)
V<SUB><IT>0</IT></SUB>[EBD]<SUB><IT>0</IT></SUB><IT>=</IT>V<SUB><IT>t</IT></SUB>[EBD]<SUB><IT>t</IT></SUB> (1)

V<SUB><IT>t</IT></SUB><IT>=</IT>V<SUB><IT>0</IT></SUB>[EBD]<SUB><IT>0</IT></SUB><IT>/</IT>[EBD]<SUB><IT>t</IT></SUB> (2)

J=(V<SUB><IT>t</IT></SUB><IT>−</IT>V<SUB><IT>0</IT></SUB>)<IT>/t</IT> (3)
where V0 is the initial known volume instilled instilled into rat air spaces containing a known concentration of Evans blue dye-albumin [EBD]0; Vt and [EBD]t are the alveolar fluid volume and EBD concentration in the instillate at time t, respectively; and J is the volume flux during a time period (t).

The sodium concentration is equal and constant in all the compartments, and because 22Na+ is instilled only in the air space, the disappearance of the radioactive tracer from the air spaces reflects the total or unidirectional Na+ outflux from the air space (JNa,out). The passive or bidirectional Na+ flux between the air space and the other compartments is the difference between the unidirectional JNa,out and active Na+ outflux (JNa,net = [Na+]J). The passive sodium movement can be calculated by
J<SUB>Na,in</SUB><IT>=</IT>[Na<SUP><IT>+</IT></SUP>]<IT>J</IT>(lnC<SUB><IT>t</IT></SUB><IT>−</IT>lnC<SUB><IT>0</IT></SUB>)<IT>/</IT>(lnV<SUB><IT>t</IT></SUB><IT>−</IT>lnV<SUB><IT>0</IT></SUB>) (4)
where C0 and Ct are the concentrations of 22Na+ initially and at time t, respectively, and [Na+] is the constant Na+ concentration in the buffered salt albumin solution.

Similarly, the mannitol flux [typically expressing the surface area permeability (PA)] is given by
P<SUB>A</SUB><IT>=J</IT>(lnM<SUB><IT>t</IT></SUB><IT>−</IT>lnM<SUB><IT>0</IT></SUB>)<IT>/</IT>(lnV<SUB><IT>t</IT></SUB><IT>−</IT>lnV<SUB><IT>0</IT></SUB>) (5)
where M0 and Mt are [3H]mannitol concentrations initially and at time t, respectively.

The fraction of FITC-albumin that appears in the alveolar space during the experimental protocol was used to calculate the albumin flux from the pulmonary circulation into the alveolar space.

Study groups. One hundred nineteen specific pathogen-free male Sprague-Dawley rats (275-325 g) were acquired from Harlan Sprague Dawley (Indianapolis, IN). DA, ISO, SCH-23390, colchicine, and beta -lumicolchicine were purchased from Sigma Chemical. Ouabain and propranolol were purchased from RBI (Natick, MA), and fenoldopam was generously provided by Neurex (Menlo Park, CA).

Control group of rats studied at Pla 0 cmH2O (n = 7) and Pla 15 cmH2O (n = 7). Rat lungs were instilled with 10-4 M DA into the air space at Pla 0 cmH2O (n = 8) and Pla 15 cmH2O (n = 7). Rat lungs were perfused with 10-6 M ISO through the pulmonary circulation at Pla 0 cmH2O (n = 6) and Pla 15 cmH2O (n = 6).

To evaluate the dopaminergic D1-receptor pathway, we studied alveolar fluid reabsorption by instilling 10-6 M fenoldopam, a specific D1-receptor agonist, into rat air spaces exposed to Pla 15 cmH2O (n = 6). We also studied the effect of dopaminergic receptor-1 antagonist SCH-23390 by instilling rat lungs with 10-4 M SCH-23390 into the air space at Pla 15 cmH2O either alone (n = 3) or with 10-4 M DA (n = 4).

To evaluate the beta -adrenergic pathway, we instilled the beta -adrenergic blocker 10-4 M propranolol into the rat air spaces at Pla 15 cmH2O either alone (n = 5) or in the presence of 10-4 M DA (n = 5) or ISO 10-6 M (n = 5).

To examine the contributory role of the amiloride-sensitive Na+ pathways and basolateral Na+-K+-ATPase on dopaminergic effects, we instilled 10-4 M amiloride (Na+ channel blocker) into the rat air spaces (n = 4) and perfused the lungs with 5 × 10-4 M ouabain (Na+-K+-ATPase blocker) either alone (n = 7) or both agents together (n = 6) in rat lungs exposed to Pla 15 cmH2O and in the presence of DA (amiloride + DA, n = 4, ouabain + DA, n = 6, and both antagonists with DA, n = 4) in rat lungs with Pla 15 cmH2O.

To evaluate the role of cell microtubular transport system on alveolar fluid reabsorption modulation by dopamine, we studied rats treated with colchicine (0.25 mg/100 g body wt) injected intraperitoneally 15 h before the experiments at Pla 15 cmH2O either alone (n = 5) or with 10-4 M DA (n = 6) instilled into the rat air spaces. We also studied the effects of 0.25 mg/100 g body wt of beta -lumicolchicine injected intraperitoneally 15 h before the experiments at Pla 15 cmH2O either alone (n = 4) or with 10-4 M DA (n = 4) instilled into the rat air spaces. beta -Lumicolchicine is an isomer of colchicine that does not bind tubulin and does not depolymerize microtubules; however, it shares other properties of colchicine, such as inhibition of protein synthesis (37).

Statistical analysis. Data are presented as means ± SE; n is the number of animals in each study group. One-way analysis of variance was used when multiple comparisons were made followed by a multiple comparison test (Tukey's) when the F statistic indicated significance. Results were considered significant when P < 0.05.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS AND MATERIALS
RESULTS
DISCUSSION
REFERENCES

Alveolar fluid reabsorption. As depicted in Fig. 1, alveolar fluid reabsorption in rat lungs exposed to Pla of 15 cmH2O was decreased by ~45% compared with control rats with Pla of 0 cmH2O (from 0.51 ± 0.02 to 0.27 ± 0.02 ml/h, P < 0.001). Treatment with DA or ISO restored alveolar fluid reabsorption to control levels in rat lungs exposed to elevated Pla (0.44 ± 0.03 and 0.52 ± 0.02 ml/h, respectively).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   Dopamine (DA) and isoproterenol (ISO) increased alveolar fluid reabsorption in rat lungs exposed to left atrial pressure (Pla) of 0 (left) and 15 cmH2O (right). Bars represent means ± SE. *P < 0.001 vs. control (CT) group with Pla 0 cmH2O; +P < 0.001 vs. control group with Pla 0 cmH2O.

To determine whether the effects of DA in rat lungs exposed to increased Pla occurred via D1 receptors, 10-6 M fenoldopam (a specific D1 agonist) were instilled into the air spaces. Fenoldopam increased alveolar fluid reabsorption to control levels (0.47 ± 0.04 ml/h). As shown in Fig. 2A, instillation of the specific D1 antagonist SCH-23390 in the rat air spaces prevented the DA-mediated increase in alveolar fluid reabsorption. As depicted in Fig. 2B, the instillation of the beta -adrenergic-receptor antagonist 10-4 M propranolol inhibited the stimulatory effects of ISO; however, in DA-treated lungs, propranolol did not affect the rate of alveolar fluid reabsorption.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   A: fenoldopam (Fen) increased alveolar fluid reabsorption in rat lungs exposed to Pla of 15 cmH2O compared with CT. SCH-23390 prevented the DA-mediated increase in lung liquid clearance in rats exposed to Pla 15 cmH2O. *P < 0.01 vs. other study groups. B: propranolol (PRO) inhibited the stimulatory effects of ISO; however, it did not affect lung liquid clearance in the CT group or when instilled together with DA. Bars represent means ± SE. *P < 0.001 vs. the other study groups.

As shown in Fig. 3, instillation of 10-4 M amiloride into the air spaces and/or the perfusion of 5 × 10-4 M ouabain in the pulmonary circulation inhibited alveolar fluid reabsorption in rat lungs with Pla of 15 cmH2O. These data suggest that DA increased alveolar fluid reabsorption in this model by regulating the amiloride-sensitive Na+ pathways and Na+-K+-ATPase in the alveolar epithelium.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3.   Alveolar fluid reabsorption was inhibited in rat lungs perfused with 5 × 10-4 M ouabain (OUAB) and/or instilled with 10-4 M amiloride (AMI). DA did not stimulate clearance in the presence of these antagonists (AMI vs. AMI + DA, OUAB vs. OUAB + DA, OUAB + AMI vs. OUAB + AMI + DA), P > 0.05. Bars represent means ± SE. *P < 0.05 vs. DA-treated rats and both CT groups; +P < 0.001 vs. CT group and DA groups exposed to Pla 15 cmH2O.

As depicted in Fig. 4, alveolar fluid reabsorption was decreased in rats pretreated with either colchicine or beta -lumicolchicine and then exposed to increased Pla compared with control rats (from 0.51 to 0.18 ± 0.07 to 0.34 ± 0.01 ml/h). Treatment with DA increased alveolar fluid reabsorption in beta -lumicolchicine-treated rats to 0.50 ± 0.04 ml/h but had no effects in the colchicine-treated rats.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of DA on lung liquid clearance was inhibited by colchicine (COL) in rats exposed to Pla 15 cmH2O. However, beta -lumicolchicine (LUM) did not block the stimulatory effects of DA. The difference between CT and COL groups in rat lungs with Pla of 15 cmH2O was not statistically significant (P > 0.05). Bars represent means ± SE. *P < 0.01 vs. CT group of Pla 0 cmH2O.

Epithelial permeability. As shown in Table 1, alveolar epithelial permeability to the small solutes, as measured by 22Na+ and [3H+]mannitol flux, was significantly increased in the rat lungs exposed to Pla of 15 cmH2O compared with control rats. The movement of FITC-albumin from the pulmonary circulation into the air spaces was slightly increased in all rat lungs exposed to Pla 15 cmH2O compared with control rats (Pla 0 cmH2O).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Alveolar epithelial permeability to small solutes

The pulmonary circulation flow rate did not change among the different study groups (Table 1). The Na+ concentration was ~135 meq/ml in all compartments: instillate, perfusate, and pleural bath.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS AND MATERIALS
RESULTS
DISCUSSION
REFERENCES

During congestive heart failure with increased Pla, patients can develop cardiogenic pulmonary edema. Recently, it has been shown that, in animal models of increased pulmonary vascular pressures, there is not only increased edema formation but also impairment of alveolar fluid reabsorption (7, 22, Saldias et al., unpublished observations). Additionally, in some patients with hydrostatic pulmonary edema, the alveolar fluid reabsorption was preserved, whereas in other patients, the ability to clear edema was impaired (35). We reason that, in patients suffering from chronic heart failure, the neurohumoral axis is activated, which results in increased endogenous catecholamines (8, 10, 30). Thus it is possible that, in patients with increased levels of endogenous catecholamines, alveolar fluid reabsorption is preserved (20, 21). We report here that, in an isolated rat lung model with acute increase in Pla, there was decreased alveolar fluid reabsorption. Our data are concordant with a previous report showing that the alveolar fluid clearance was normal in sheep exposed to moderate left atrial hypertension. In contrast, in adrenalectomized sheep where the secretion of endogenous catecholamines was abolished, the clearance was significantly reduced (7).

DA has been used clinically to induce natriuresis in patients with pulmonary edema by inhibiting the Na+-K+-ATPase activity in the renal tubular epithelium (17). In contrast, DA enhanced active Na+ transport and increased alveolar fluid reabsorption in normal rat lungs and in a model of lung injury induced by exposure of rats to 100% oxygen for 64 h (3, 27). In accord with these data, we are reporting that, in a model of increased Pla, DA, via the D1 receptors, and ISO, via activation of beta -adrenergic receptors, increased alveolar fluid reabsorption. These effects were blocked by the D1-receptor antagonist SCH-23390 and increased by the D1 agonist fenoldopam (Fig. 2A). The beta -adrenergic-receptor antagonist propranolol did not inhibit the stimulatory effects of DA (Fig. 2B). These results suggest that the DA effects in this model are mediated by the dopaminergic (D1) and not the beta -adrenergic pathway.

The effects of DA and ISO were inhibited by ouabain and amiloride, confirming that beta -adrenergic and dopaminergic agonists increase lung edema clearance by stimulating the alveolar epithelial Na+-K+-ATPase function and amiloride-sensitive Na+ pathways in rat lungs with increased Pla (Fig. 3), as has been previously reported in control rats (3, 4, 28). Upregulation of Na+-K+-ATPase function could be due to increased transcription, translation, protein assembly, recruitment, and translocation to the plasma membrane from intracellular pools and metabolic activation (5, 6).

Recent studies have suggested that the cell microtubular transport system and cytoskeleton proteins are involved in Na+ pump recruitment from intracellular pools to the plasma membrane (6). Therefore, we tested in physiological experiments whether the stimulatory effects of DA and ISO in rat lungs exposed to increased Pla occur by stimulation of preexisting membrane-bound Na+ pumps or by recruitment of Na+-K+- ATPase proteins from intracellular pools to the cell plasma membrane. We reasoned that cell microtubular transport disruption by colchicine could provide information about whether the stimulatory effects of DA and ISO on active Na+ transport and lung edema clearance in rat lungs with increased Pla could be due to Na+ pump recycling. We indeed observed that colchicine inhibited DA stimulation of edema clearance in rat lungs with increased Pla (Fig. 4). Meanwhile, the isomer beta -lumicolchicine, which shares many colchicine properties with the exception of inhibiting cell microtubular transport (27, 28), did not inhibit the DA modulation of lung edema clearance. These results suggest that, in a model of increased Pla, DA and ISO upregulation of lung edema clearance is mediated by recruitment of Na+ pumps from intracellular pools to the plasma membrane of alveolar epithelial cells.

The data presented in this report support the notion that increased pulmonary capillary hydrostatic pressures represent a model of lung injury that impairs alveolar fluid reabsorption. Our data agree with reports in sheep (7, 11) and rats (Saldias et al., unpublished observations) in which the rate of alveolar fluid reabsorption was impaired when hydrostatic pulmonary circulation pressures were increased.

The epithelial permeability to small solutes and to albumin was slightly increased compared with rat groups with normal Pla. These observations are similar to studies in which increased permeability of tracers across the alveolocapillary barrier was reported when Pla increased (19, 34, 36). We reason that this is possibly due to capillary stress failure or stretch pore phenomena that may transiently affect the permeability of the alveolocapillary barrier (2, 36).

This report demonstrates the beneficial effects of DA and ISO by improving alveolar fluid reabsorption in a model of increased hydrostatic pulmonary circulation pressures. Left heart failure with resultant decrease in effective arterial volume is characterized mainly by decreased cardiac output and left atrial enlargement (1, 14). Consequently, this may lead to increased levels of atrial natriuretic peptides, angiotensin II, endothelin, and possibly endogenous ouabain-like substances (12, 15, 24, 30). It has been reported that atrial natriuretic peptides instilled in the rat air spaces decreased the active Na+ transport and alveolar fluid reabsorption (18, 33). Also, endogenous ouabain-like substances may decrease alveolar fluid reabsorption by inhibiting alveolar Na+-K+-ATPase. We reason that DA and ISO can counteract these decreases in active Na+ transport and increase alveolar fluid reabsorption.

In summary, we report that DA and ISO increase alveolar fluid reabsorption in a model of increased Pla. The effects of DA are mediated by the activation of dopaminergic D1 receptors, whereas the effects of ISO are mediated by the activation of beta -adrenergic receptors that cause an upregulation of the amiloride-sensitive Na+ pathways and Na+-K+-ATPase. This new information is of potential clinical relevance in the treatment of patients with cardiogenic pulmonary edema.


    ACKNOWLEDGEMENTS

This study was supported in part by National Heart, Lung, and Blood Institute Grants HL-48129 and HL-65161, National Research Service Award HL-09806, and Pontificia Universidad Catolica de Chile FONDECYT 1990515.


    FOOTNOTES

Address for reprint requests and other correspondence: J. I. Sznajder, Pulmonary and Critical Care Medicine, Northwestern Univ., Tarry 14-707, 300 E. Superior St., Chicago, IL 60611 (E-mail: j-sznajder{at}northwestern.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 3 May 2000; accepted in final form 12 September 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS AND MATERIALS
RESULTS
DISCUSSION
REFERENCES

1.   Anand, IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, and Harris PC. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 80: 299-305, 1989[Abstract/Free Full Text].

2.   Bachofen, H, Schurch S, and Weibel ER. Experimental hydrostatic pulmonary edema in rabbit lungs. Barrier lesions. Am Rev Respir Dis 147: 997-1004, 1993[ISI][Medline].

3.   Barnard, ML, Olivera WG, Rutschman DM, Bertorello AM, Katz AI, and Sznajder JI. Dopamine stimulates sodium transport and liquid clearance in rat lung epithelium. Am J Respir Crit Care Med 156: 709-714, 1997[Abstract/Free Full Text].

4.   Barnard, ML, Ridge KM, Saldias F, Friedman E, Gare M, Guerrero C, Lecuona E, Bertorello AM, Katz AI, and Sznajder JI. Stimulation of the dopamine 1 receptor increases lung edema clearance. Am J Respir Crit Care Med 160: 982-986, 1999[Abstract/Free Full Text].

5.   Berthiaume, Y, Staub NC, and Matthay MA. Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 79: 335-343, 1987.

6.   Bertorello, AM, Ridge KM, Chibalin AV, Katz AI, and Sznajder JI. Isoproterenol increases Na+-K+-ATPase activity by membrane insertion of alpha -subunits in lung alveolar cells. Am J Physiol Lung Cell Mol Physiol 276: L20-L27, 1999[Abstract/Free Full Text].

7.   Campbell, AR, Folkesson HG, Berthiaume Y, Gutkowska J, Suzuki S, and Matthay MA. Alveolar epithelial fluid clearance persists in the presence of moderate left atrial hypertension in sheep. J Appl Physiol 86: 139-151, 1999[Abstract/Free Full Text].

8.   Cohn, JN, Levine TB, Francis GS, and Goldsmith S. Neurohumoral control mechanisms in congestive heart failure. Am Heart J 102: 509-514, 1981[ISI][Medline].

9.   Crandall, ED, Heming TA, Palombo RL, and Goodman BE. Effects of terbutaline on sodium transport in isolated perfused rat lung. J Appl Physiol 60: 289-294, 1986[Abstract/Free Full Text].

10.   Francis, GS, Goldsmith SR, Levine TB, Olivari MT, and Cohn JN. The neurohumoral axis in congestive heart failure. Ann Intern Med 101: 370-377, 1984.

11.   Frank, JA, Wang Y, Osorio O, and Matthay MA. beta -Adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats. J Appl Physiol 89: 1255-1265, 2000[Abstract/Free Full Text].

12.   Gottlieb, SS, Rogowski AC, Weinberg M, Krichten CM, Hamilton BP, and Hamlyn JM. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 86: 420-425, 1992[Abstract/Free Full Text].

13.   Gropper, MA, Wiener-Kronish JP, and Hashimoto S. Acute cardiogenic pulmonary edema. Clin Chest Med 15: 501-515, 1994[ISI][Medline].

14.   Katz, AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 322: 100-110, 1990[ISI][Medline].

15.   Luscher, TF. Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties. Am Rev Respir Dis 146: S56-S60, 1992[ISI][Medline].

16.   Matthay, MA, Folkesson HG, and Verkman AS. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol Lung Cell Mol Physiol 270: L487-L503, 1996[Abstract/Free Full Text].

17.   Meister, B, and Aperia A. Molecular mechanisms involved in catecholamine regulation of sodium transport. Semin Nephrol 13: 41-49, 1993[ISI][Medline].

18.   Olivera, W, Ridge K, Wood LD, and Sznajder JI. ANF decreases active sodium transport and increases alveolar epithelial permeability in rats. J Appl Physiol 75: 1581-1586, 1993[Abstract/Free Full Text].

19.   Pietra, GG, Szidon JP, Leventhal MM, and Fishman AP. Hemoglobin as a tracer in hemodynamic pulmonary edema. Science 166: 1643-1646, 1969[Abstract/Free Full Text].

20.   Pittet, JF, Brenner TJ, Modelska K, and Matthay MA. Alveolar liquid clearance is increased by endogenous catecholamines in hemorrhagic shock in rats. J Appl Physiol 81: 830-837, 1996[Abstract/Free Full Text].

21.   Pittet, JF, Wiener-Kronish JP, McElroy MC, Folkesson HG, and Matthay MA. Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats. J Clin Invest 94: 663-671, 1994.

22.   Raj, JU, and Bland RD. Lung luminal liquid clearance in newborn lambs. Effect of pulmonary microvascular pressure elevation. Am Rev Respir Dis 134: 305-310, 1986[ISI][Medline].

23.   Rutschman, DH, Olivera W, and Sznajder JI. Active transport and passive liquid movement in isolated perfused rat lungs. J Appl Physiol 75: 1574-1580, 1993[Abstract/Free Full Text].

24.   Sakai, S, Miyauchi T, Sakurai T, Yamaguchi I, Kobayashi M, Goto K, and Sugishita Y. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats. J Am Coll Cardiol 28: 1580-1588, 1996[Abstract].

26.   Saldias, FJ, Comellas A, Ridge KM, Lecuona E, and Sznajder JI. Isoproterenol improves ability of lung to clear edema in rats exposed to hyperoxia. J Appl Physiol 87: 30-35, 1999[Abstract/Free Full Text].

27.   Saldias, FJ, Lecuona E, Comellas AP, Ridge KM, and Sznajder JI. Dopamine restores lung ability to clear edema in rats exposed to hyperoxia. Am J Respir Crit Care Med 159: 626-633, 1999[Abstract/Free Full Text].

28.   Saldias, F, Lecuona E, Friedman E, Barnard ML, Ridge KM, and Sznajder JI. Modulation of lung liquid clearance by isoproterenol in rat lungs. Am J Physiol Lung Cell Mol Physiol 274: L694-L701, 1998[Abstract/Free Full Text].

29.   Saumon, G, and Basset G. Electrolyte and fluid transport across the mature alveolar epithelium. J Appl Physiol 74: 1-15, 1993[Abstract/Free Full Text].

30.   Schrier, RW, and Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 341: 577-585, 1999[Free Full Text].

31.   Soltoff, SP, and Mandel LJ. Amiloride directly inhibits the Na+-K+-ATPase activity of rabbit kidney proximal tubules. Science 220: 957-958, 1983[Abstract/Free Full Text].

32.   Staub, NC. Pulmonary edema. Physiol Rev 54: 678-811, 1974[Free Full Text].

33.   Tharaux, PL, Dussaule JC, Couette S, and Clerici C. Evidence for functional ANP receptors in cultured alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 274: L244-L251, 1998[Abstract/Free Full Text].

34.   Tsukimoto, K, Yoshimura N, Ichioka M, Tojo N, Miyazato I, Marumo F, Mathieu-Costello O, and West JB. Protein, cell, and LTB4 concentrations of lung edema fluid produced by high capillary pressures in rabbit. J Appl Physiol 76: 321-327, 1994[Abstract/Free Full Text].

35.   Verghese, GM, Ware LB, Matthay BA, and Matthay MA. Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema. J Appl Physiol 87: 1301-1312, 1999[Abstract/Free Full Text].

36.   West, JB, and Mathieu-Costello O. Vulnerability of pulmonary capillaries in heart disease. Circulation 92: 622-631, 1995[Abstract/Free Full Text].

37.   Wilson, L, and Friedkin M. The biochemical events of mitosis. I. Synthesis and properties of colchicine labeled with tritium in its acetyl moiety. Biochemistry 5: 2463-2468, 1966[Medline].


J APPL PHYSIOL 90(3):1088-1094
8750-7587/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. G. Gandhi, B. Rafii, M. S. Harris, A. Garces, D. Mahuran, X.-J. Chen, H.-F. Bao, L. Jain, D. C. Eaton, G. Otulakowski, et al.
Effects of cardiogenic edema fluid on ion and fluid transport in the adult lung
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L651 - L659.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Z. S. Azzam, Y. Adir, L. Welch, J. Chen, J. Winaver, P. Factor, N. Krivoy, A. Hoffman, J. I. Sznajder, and Z. Abassi
Alveolar fluid reabsorption is increased in rats with compensated heart failure
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1094 - L1100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. N. Helms, J. Self, H. F. Bao, L. C. Job, L. Jain, and D. C. Eaton
Dopamine activates amiloride-sensitive sodium channels in alveolar type I cells in lung slice preparations
Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L610 - L618.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Litvan, A. Briva, M. S. Wilson, G. R. S. Budinger, J. I. Sznajder, and K. M. Ridge
beta-Adrenergic Receptor Stimulation and Adenoviral Overexpression of Superoxide Dismutase Prevent the Hypoxia-mediated Decrease in Na,K-ATPase and Alveolar Fluid Reabsorption
J. Biol. Chem., July 21, 2006; 281(29): 19892 - 19898.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. M. Bertorello and J. I. Sznajder
The Dopamine Paradox in Lung and Kidney Epithelia: Sharing the Same Target but Operating Different Signaling Networks
Am. J. Respir. Cell Mol. Biol., November 1, 2005; 33(5): 432 - 437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. M. Mutlu and J. I. Sznajder
Mechanisms of pulmonary edema clearance
Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L685 - L695.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. A. Matthay, L. Robriquet, and X. Fang
Alveolar Epithelium: Role in Lung Fluid Balance and Acute Lung Injury
Proceedings of the ATS, October 1, 2005; 2(3): 206 - 213.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kunzelmann, J. Konig, J. Sun, D. Markovich, N. J. King, G. Karupiah, J. A. Young, and D. I. Cook
Acute Effects of Parainfluenza Virus on Epithelial Electrolyte Transport
J. Biol. Chem., November 19, 2004; 279(47): 48760 - 48766.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
J. M. Liebler, Z. Borok, X. Li, B. Zhou, A. J. Sandoval, K.-J. Kim, and E. D. Crandall
Alveolar Epithelial Type I Cells Express {beta}2-Adrenergic Receptors and G-protein Receptor Kinase 2
J. Histochem. Cytochem., June 1, 2004; 52(6): 759 - 767.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. M. Mutlu, V. Dumasius, J. Burhop, P. J. McShane, F. J. Meng, L. Welch, A. Dumasius, N. Mohebahmadi, G. Thakuria, K. Hardiman, et al.
Upregulation of Alveolar Epithelial Active Na+ Transport Is Dependent on {beta}2-Adrenergic Receptor Signaling
Circ. Res., April 30, 2004; 94(8): 1091 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Y. Adir, Z. S. Azzam, E. Lecuona, S. Leal, L. Pesce, V. Dumasius, A. M. Bertorello, P. Factor, J. B. Young, K. M. Ridge, et al.
Augmentation of Endogenous Dopamine Production Increases Lung Liquid Clearance
Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 757 - 763.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Sugita, P. Ferraro, A. Dagenais, M.-E. Clermont, P. Barbry, R. P. Michel, and Y. Berthiaume
Alveolar Liquid Clearance and Sodium Channel Expression Are Decreased in Transplanted Canine Lungs
Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1440 - 1450.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. P. Comellas, L. M. Pesce, Z. Azzam, F. J. Saldias, and J. I. Sznajder
Scorpion Venom Decreases Lung Liquid Clearance in Rats
Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1064 - 1067.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. A. Matthay
Alveolar Fluid Clearance in Patients With ARDS: Does It Make a Difference?
Chest, December 1, 2002; 122(6_suppl): 340S - 343S.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. I. Sznajder, P. Factor, and D. H. Ingbar
Lung Edema Clearance: 20 Years of Progress: Invited Review: Lung edema clearance: role of Na+-K+-ATPase
J Appl Physiol, November 1, 2002; 93(5): 1860 - 1866.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. B. Ware, X. Fang, Y. Wang, T. Sakuma, T. S. Hall, and M. A. Matthay
Lung Edema Clearance: 20 Years of Progress: Selected Contribution: Mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung
J Appl Physiol, November 1, 2002; 93(5): 1869 - 1874.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. Sartori, X. Fang, D. W. McGraw, P. Koch, M. E. Snider, H. G. Folkesson, and M. A. Matthay
Lung Edema Clearance: 20 Years of Progress: Selected Contribution: Long-term effects of beta 2-adrenergic receptor stimulation on alveolar fluid clearance in mice
J Appl Physiol, November 1, 2002; 93(5): 1875 - 1880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. L. Fisher and S. S. Margulies
Na+-K+-ATPase activity in alveolar epithelial cells increases with cyclic stretch
Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L737 - L746.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. A. Matthay, H. G. Folkesson, and C. Clerici
Lung Epithelial Fluid Transport and the Resolution of Pulmonary Edema
Physiol Rev, July 1, 2002; 82(3): 569 - 600.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Factor, Z. A. Azzam, G. M. Mutlu, J. I. Sznajder, and V. Dumasius
Enhancement of Alveolar Epithelial {beta}2-Adrenergic Receptor Function Via Gene Transfer
Chest, March 1, 2002; 121(2007): 45S - 46S.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. S. Azzam, V. Dumasius, F. J. Saldias, Y. Adir, J. I. Sznajder, and P. Factor
Na,K-ATPase Overexpression Improves Alveolar Fluid Clearance in a Rat Model of Elevated Left Atrial Pressure
Circulation, January 29, 2002; 105(4): 497 - 501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. J. Saldias, Z. S. Azzam, K. M. Ridge, A. Yeldandi, D. H. Rutschman, D. Schraufnagel, and J. I. Sznajder
Alveolar fluid reabsorption is impaired by increased left atrial pressures in rats
Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L591 - L597.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response